Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q3 2019 · 10-Q
Revenue—
Net Income$526.00K$526.00KN/M vs Q3 2018 EPS Diluted-$0.03-$0.03N/M vs Q3 2018 Operating Income$2,680,000N/M Operating Cash Flowderived-$2,522,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Free Cash Flowderived-$2,524,000N/M ended Sep 30, 2019 · filed Nov 14, 2019 · 45 d after period end